UroGen Pharma URGN Debt issuance costs and discount amortization
Debt issuance costs and discount amortization at other companies
Other financials
Where this comes from
Reported directly by UroGen Pharma in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfDebtDiscountPremium.
The official record: UroGen Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about UroGen Pharma's debt issuance costs and discount amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is UroGen Pharma's debt issuance costs and discount amortization?
- UroGen Pharma (URGN) reported debt issuance costs and discount amortization of $1.97M in Q1 2026.
- How has UroGen Pharma's debt issuance costs and discount amortization changed year-over-year?
- UroGen Pharma's debt issuance costs and discount amortization increased by 427.8% year-over-year, from $374K to $1.97M.
- What does debt issuance costs and discount amortization mean?
- Captures the non-cash expense related to the systematic amortization of debt issuance costs and original issue discounts over the life of a debt instrument. It effectively increases the reported interest expense to reflect the true effective interest rate of the company's borrowings.